-- 独立研究机构CFRA向提供了以下研究报告。CFRA分析师总结如下：诺斯罗普·格鲁曼公司（NOC）公布了强劲的第一季度业绩，销售额同比增长4.4%至99亿美元（超出市场预期1.25亿美元），每股收益同比增长85%至6.14美元（超出市场预期0.14美元），主要得益于去年4.77亿美元的B-21损失准备金不再计提。航空系统业务由1.83亿美元的运营亏损转为3.05亿美元的盈利，反映了运营的复苏和B-21生产协议的达成。本季度业绩进一步印证了我们此前的观点，即在去年计提B-21损失准备金后，NOC的业绩正在趋于稳定，战略威慑和弹药项目的逐步推进支撑了其潜在的增长。管理层强调了B-21产能扩张，并重申了2026年自由现金流预期为31亿至35亿美元，但同时暂停了股票回购，以资助内生性投资。我们认为，956亿美元的积压订单能够确保未来多年的收入可见性，但复杂研发项目的执行风险依然存在。我们认为，公司未来的增长轨迹很大程度上取决于B-21产能的加速提升以及未来12至18个月内“哨兵”导弹基线的稳定性。
Related Articles
Mining & Metals
Stifel Canada Hikes Aritzia Price Target to $158.00
Stifel Canada is expecting another strong quarter from Aritzia (ATZ.TO) when it reports its fiscal fourth-quarter earnings on May 7.Analyst Martin Landry, who is raising his price target on the company's shares by $8.00 to $158.00 and maintaining a buy rating, is also hiking comparable sales growth expectation by 700bps to 21% Y/Y, higher than consensus of 18%."We expect Aritzia to introduce a FY27 guidance higher than current consensus expectations, potentially driving upwards earnings revisions," Landry adds. Aritzia shares touched an all-time high on Friday as investors are pricing the company's strong operational performance.Landry also expects earnings per share growth of 34% Y/Y in fiscal 27, higher than peers.Price: $139.87, Change: $-3.34, Percent Change: -2.33%
$ATZ.TO
Australia
HCA Healthcare Pressure Expected to Persist Through Q2 on Managed Care Rotation, RBC Says
HCA Healthcare (HCA) may face near-term pressure through at least the first half as investors rotate toward managed care, although better trends in March and in-line exchange dynamics support the longer-term outlook, RBC Capital Markets said.The company's weaker-than-expected Q1, driven by lower respiratory volume and weather-related disruption, has increased near-term concern around hospital volumes and patient mix.RBC said in a Sunday note that it expects Friday's share price decline to persist through Q2 as management works to demonstrate execution against growth targets and as investors await further clarity on the impact of ePTC expiry.The investment firm said March volumes improved meaningfully while exchange-related pressure remains manageable. HIX declines reflect both lost volume and patients in grace periods already incorporated into bad debt reserves. Surgical and outpatient trends remain broadly consistent with its full-year outlook, according to the note.RBC reiterated its outperform rating and lowered its price target to $534 from $593, citing increased caution on near-term hospital volume and mix dynamics and a broader rotation toward managed care.Price: $439.41, Change: $+6.95, Percent Change: +1.61%
$HCA
Mining & Metals
BluEnergies Announces DTC Eligibility
BluEnergies (BLU.V) shares are now eligible for electronic clearing and settlement in the United States through the Depository Trust Company (DTC), BluEnergies said on Monday.The company's shares recently began trading on the OTCQX Best Market under the ticker BLUGF, it added."Obtaining DTC eligibility marks an important step in expanding BLU's investor base and enhancing accessibility for shareholders," said chief executive Craig Steinke. "For investors, DTC eligibility is a key milestone that streamlines electronic trading and supports improved liquidity, which is especially important as we advance the development of our assets in the Harper Basin, Liberia and Gulf of America and continue to build long-term value across our portfolio."The company's shares were last seen down $0.09, or 3.1%, to $2.73 on the TSX Venture Exchange.Price: $2.73, Change: $-0.09, Percent Change: -3.19%
$BLU.V